Glovax Lifescience

Glovax Lifescience, operating primarily as Glovax Biotech, is a biopharmaceutical company headquartered in the Philippines dedicated to the development, importation, and distribution of life-saving vaccines. The company's portfolio includes vaccines for a wide range of infectious diseases, such as influenza, polio, hepatitis B, and rabies, aimed at improving public health accessibility in Southeast Asia. Glovax has gained international recognition for its collaboration with South Korean biotech EuBiologics to bring the EuCorVac-19 COVID-19 vaccine to the Philippine market. Beyond distribution, the company is actively pursuing the establishment of the Philippines' first domestic vaccine manufacturing plant to ensure long-term vaccine security. This strategic initiative positions Glovax as a key player in the regional effort to combat emerging viral threats and reduce reliance on imported biologicals.